Gilead Sciences’ experimental drug remdesivir, seen as one of the more promising potential treatments for the coronavirus, received the orphan drug designation from the U.S. Food and Drug Administration.
— Read on www.cnbc.com/2020/03/24/gileads-potential-coronavirus-treatment-gets-fdas-orphan-drug-label.html
Skip to content